The Totally Civil Covid Thread.

  • Ablaufdatum erreicht – Bund entsorgt über 10 Millionen Moderna-Impfdosen
    Der Wert der abgelaufenen Dosen liegt wohl im dreistelligen Millionenbereich. Gleichzeitig treffen 3,5 Millionen neue angepasste Moderna-Impfdosen ein.
    www.tagesanzeiger.ch


    This is how the mafia works. Fake orders for vaccine and claiming >10 million dose are now scratched.


    We already dumped more vaccines than we ever did administrate... Luckily...

  • Covid interrupts vitamin d expression thru CYP2R1 genes. Inturn APOE proliferates, you die. Raising vitamin d levels to 50-70ng/mL will compensate



    Explaining the Most Baffling Quirk of COVID: Common Gene Variant Linked to Mortality

    Explaining the Most Baffling Quirk of COVID: Common Gene Variant Linked to Mortality
    It may be the most baffling quirk of COVID: While some infected individuals only have minor, flu-like symptoms, in others COVID-19 can spiral into severe…
    scitechdaily.com


    It may be the most baffling quirk of COVID: While some infected individuals only have minor, flu-like symptoms, in others COVID-19 can spiral into severe disease, disability, and even death. A new research paper published on September 21 in the journal Nature may explain the genetic underpinnings of this dichotomy.


    In their latest research, scientists showed that mice with gene variants previously linked to Alzheimer’s disease were at a greater risk of dying when infected with SARS-CoV-2, the virus that causes COVID-19. In addition, a retrospective analysis indicates that patients with those same gene variants were more likely to have died of COVID throughout the pandemic. With 3% of the world population possessing these gene variants, the findings may have implications for hundreds of millions of individuals worldwide.


    “It is clear that age, sex, and certain preconditions such as diabetes increase the risk of detrimental outcomes, but these factors don’t fully explain the spectrum of COVID outcomes,” says Sohail Tavazoie, M.D., Ph.D. He is the Leon Hess Professor, Howard Hughes Medical Institute Faculty Scholar and Head of the Meyer Laboratory of Systems Cancer Biology at The Rockefeller University. “This is the first time that we’ve seen such a common genetic variant associated with COVID mortality.”



    APOE4 gene problems (Alzheimer’s) reduced by both Vitamin D and Omega-3 - Dec 2018


    Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients

    https://pubmed.ncbi.nlm.nih.go…roid,sporadic%20Alzheimer's%20disease%20(AD).

  • Tweaked vaccine no better than original crap




    External Content youtu.be
    Content embedded from external sources will not be displayed without your consent.
    Through the activation of external content, you agree that personal data may be transferred to third party platforms. We have provided more information on this in our privacy policy.

  • FDA vaccine adviser warns healthy young people should NOT get new COVID booster: Says it's 'unfair to make them take a risk' after data suggested shot was not as effective as first batch

    FDA adviser says healthy young people SHOULDN'T get another booster
    Dr. Paul Offit, a member of the FDA's Vaccine Advisory Committee, said he's not fully sold that the benefits of a third shot outweigh the harm and the booster…
    www.dailymail.co.uk


    Dr. Paul Offit, a member of the FDA's Vaccine Advisory Committee, said he's not fully sold on the benefits of a third shot outweighing the harm

    A newly developed dose, called a bivalent vaccine, is a cocktail of the original coronavirus strain combined with parts of the omicron BA.4 and BA.5 subvariants

    The CDC has reported that the old vaccine has side-effects like myocarditis, an - inflammation of the heart muscle and pericarditis, an inflammation of the heart's outer lining

    So far, the only tests on the new shots have been done on lab mice


    But writing in the Wall Street Journal earlier this week, Offitt said preliminary data suggested the new bivalent vaccines were actually worse at warding off COVID infections than the first generation of shots.

  • this post is more for the comic value. He was boosted a month ago.


    Pfizer CEO Tests Positive, Again, for Covid

    Pfizer CEO Tests Positive, Again, for Covid
    Albert Bourla the Chief Executive Officer (CEO) of Pfizer, tested positive for the Covid-19 virus in August.  Now, it turns out even the CEO of a big…
    www.trialsitenews.com


    Albert Bourla the Chief Executive Officer (CEO) of Pfizer, tested positive for the Covid-19 virus in August. Now, it turns out even the CEO of a big pharmaceutical company still remains vulnerable to the coronavirus. This weekend Bourla tested positive, yet again, for Covid. In a statement issued by Pfizer Bourla said: “I wanted to let you know that I have tested positive for COVID. I’m feeling well and symptom free. I’ve not had the new bivalent booster yet, as I was following CDC guidelines to wait three months since my previous COVID case which was back in mid-August. While we’ve made great progress, the virus is still with us.”


    Still Pushing the Brand

    Bourla was treated with Pfizer’s anti-viral Paxlovid when he contracted the virus in August. This time around the CEO pointed out he was following guidelines issued by the Centers for Disease Control (CDC) and hasn’t yet received Pfizer’s bivalent vaccine. The CDC recommends delaying getting the bivalent vaccine at least three months after a bout with Covid. The statement issued by Pfizer was tweeted by Bourla again pointing out progress the company has made against the pandemic but “the virus is still with us”.


    Reminiscent of Davos

    This past Spring Bourla addressed the World Economic Forum in Davos, Switzerland and warned the world was getting complacent about the novel coronavirus.


    Bourla spoke of the coming waves of Covid and the “politicization” of the virus. Bourla also said the anti-viral drugs being manufactured by Pfizer would eventually replace the vaccines. Bourla failed to mention Paxlovid didn’t do well in trials with patients with no underlying conditions and was most effective on people over 65. When Bourla spoke at Davos, Pfizer stock was declining and continues to do so. But the company expects to make a huge profit from Paxlovid this year. What seems to be ironic here is that Albert Bourla with or without Covid continues to be the ultimate “Company Man”. Perhaps his salary is justification.


    But the stock is under strain, despite over a hundred billion in revenue thanks to pandemic monetization, but if Bourla can’t keep up with investor expectation he’ll find problems even worse than his latest bout with Omicron.

  • Analysis and Ambiguity: Obscure COVID-19 Vaccine Contents

    Analysis and Ambiguity: Obscure COVID-19 Vaccine Contents
    The Working Group of Vaccine Analysis in Germany have released a report of their preliminary research, showing that contaminants and unreported components have…
    www.trialsitenews.com


    The Working Group of Vaccine Analysis in Germany have released a report of their preliminary research, showing that contaminants and unreported components have been found in all COVID-19 vaccines. Another group of experts in Germany reported findings from microscopic analysis of the vaccines in October 2021. In December 2021, TrialSite reported on the mysterious death of a German scientist who questioned the contents of the COVID-19 vaccines.


    The latest findings, released on July 6, 2022, focused on the contents of COVID-19 vaccines that had been analyzed and verified with different diagnostic methods including scanning electron microscopy (SEM), energy dispersive x-ray spectroscopy (EDX), mass spectroscopy (MS), bright field microscopy (BFM), dark field microscopy (DFM) and live blood image diagnostics. The report also showed the vaccine contents’ impact on human health, specifically on human blood cells.


    What Has Been Found in the Vaccines?

    Using dark-field microscopic blood analysis, human blood samples of mRNA-vaccinated patients were analyzed and shown to contain diverse rectangular and square crystal shapes, and spirals, across the majority of samples. The blood cells of vaccinated individuals were distinctively altered in structure, resembling those that have a serious chronic infection.


    In contrast, these novel objects were not found in non-mRNA vaccines like the Johnson & Johnson (Janssen), Lubecavax, and Influspit Tetra.


    Another concern was finding concentrations of antimony, a powder toxic to humans, in the Moderna vials. The small amount found should not be toxic, but researchers stated that it is cause for clinical monitoring and follow-up. Other metallic elements (cesium, potassium, calcium, barium, cobalt, iron, chromium, titanium, cerium, gadolinium, aluminum, silicon, and sulfur) were also found in Pfizer and Astra Zeneca mRNA vaccines. From a clinical perspective, none of these metals is inherently harmful, but in larger doses, they can become toxic or lead to side effects.


    David Hughes, PhD, is Senior Lecturer in International Relations at the University of Lincoln, UK. In an article published on September 3, 2022, in the International Journal of Vaccine Theory, Practice, and Research, Hughes presented evidence of unknown substances in COVID-19 vaccines. Evidence was sourced from 26 cases from different labs in various parts of the world. When scientists compared blood samples of unvaccinated and vaccinated individuals, the vaccinated blood appeared in a rouleaux formation, which is associated with a number of clinical conditions.


    One case that Hughes referenced was that Dr Carrie Madej found unidentifiable objects when looking at Moderna COVID vaccine contents under 400x magnification. A November 2021 fact check deemed this false, because the unidentified objects seen by Dr Madej were likely debris such as dust, skin cells, or cotton fibers.


    What Are Preprints and Why Are They Used?

    For scientific research to be published in a reputable journal, a study or article must first go through a rigorous peer-review process. Many times, after research but before peer review, study authors will publish a preprint on an open access repository like BioRxiv. This is an online server dedicated to preprints for biology. Research is considered peer-reviewed when an article has been reviewed by several objective experts in the field. Studies may go through several cycles of review before being published. This process is to ensure that accurate information is disseminated and that scientific integrity is always maintained through research. Academic journals can be quite stringent regarding this process, as no journal wants to risk compromising its credibility by accepting research papers that weren’t properly checked.


    One could argue that this is the reason we aren’t seeing more of this science come to light. In the age of misinformation and censorship, it can be a challenge to back the argument that is opposed by the vast majority. TSN covered a similar issue regarding ivermectin to treat COVID-19. Scientists struggled to get ivermectin and COVID papers published due to similar scrutiny.


    Because of backlash faced by others doing similar work, the German group members decided to remain anonymous. Researchers explained that they used a preprint format to release findings because their primary goal is to bring awareness to the general public of the dangers of these vaccines.


    The authors also stated that in the current political landscape created by the pandemic, reports such as this have not been subject to the customary peer-review process. Highly qualified colleagues from an international network critically examined this data and provided feedback prior to publishing.


    Independent Testing of Vaccine Vials

    A point to consider that has been addressed by scientists involved in this vaccine analysis research is why has there been no independent testing of vials? In the UK, vaccines are only distributed through the National Health Service (NHS). Though it is not easy for individual scientists to conduct tests, independent testing was conducted by the National Institute for Biological Standards and Control (NIBSC), a branch of the Medicines and Healthcare products Regulatory Agency (MHRA).


    The summary reported that scientists would obtain vials in unofficial ways to be able to study them. This naturally introduces doubt on any research conducted with these potentially contaminated vials. When COVID-19 vaccines are not kept at the proper temperature or are used past the expiration date, this can disrupt the contents.


    Future Research

    From the evidence at hand, it is difficult to discern what research is reliable and what is not. The working group in Germany has their findings backed by research from multiple countries, but it is not technically grounded in the rigorous scientific process necessary to make governments pay attention.


    View of What is in the so-called COVID-19 “Vaccines”? Part 1: Evidence of a Global Crime Against Humanity

  • Interesting study which explores the possibility that viral infection can lay and wait. Sounds like a possible cause of long COVID and the need to treat all early. Leaky vaccines, and I'm being kind, will not provide any protection if this is true!!!


    The transcriptional regulator CtrA controls gene expression in Alphaproteobacteria phages: Evidence for a lytic deferment pathway


    The transcriptional regulator CtrA controls gene expression in Alphaproteobacteria phages: Evidence for a lytic deferment pathway
    Pilitropic and flagellotropic phages adsorb to bacterial pili and flagella. These phages have long been used to investigate multiple aspects of bacterial…
    www.frontiersin.org


    Pilitropic and flagellotropic phages adsorb to bacterial pili and flagella. These phages have long been used to investigate multiple aspects of bacterial physiology, such as the cell cycle control in the Caulobacterales. Targeting cellular appendages for adsorption effectively constrains the population of infectable hosts, suggesting that phages may have developed strategies to maximize their infective yield. Brevundimonas phage vB_BsubS-Delta is a recently characterized pilitropic phage infecting the Alphaproteobacterium Brevundimonas subvibrioides. Like other Caulobacterales, B. subvibrioides divides asymmetrically and its cell cycle is governed by multiple transcriptional regulators, including the master regulator CtrA. Genomic characterization of phage vB_BsubS-Delta identified the presence of a large intergenic region with an unusually high density of putative CtrA-binding sites. A systematic analysis of the positional distribution of predicted CtrA-binding sites in complete phage genomes reveals that the highly skewed distribution of CtrA-binding sites observed in vB_BsubS-Delta is an unequivocal genomic signature that extends to other pilli- and flagellotropic phages infecting the Alphaproteobacteria. Moreover, putative CtrA-binding sites in these phage genomes localize preferentially to promoter regions and have higher scores than those detected in other phage genomes. Phylogenetic and comparative genomics analyses show that this genomic signature has evolved independently in several phage lineages, suggesting that it provides an adaptive advantage to pili/flagellotropic phages infecting the Alphaproteobacteria. Experimental results demonstrate that CtrA binds to predicted CtrA-binding sites in promoter regions and that it regulates transcription of phage genes in unrelated Alphaproteobacteria-infecting phages. We propose that this focused distribution of CtrA-binding sites reflects a fundamental new aspect of phage infection, which we term lytic deferment. Under this novel paradigm, pili- and flagellotropic phages exploit the CtrA transduction pathway to monitor the host cell cycle state and synchronize lysis with the presence of infectable cells.

  • From the evidence at hand, it is difficult to discern what research is reliable and what is not.

    Most people are over excited and lack a clear mind due to panic. Most so called nano structures shown in the report are wear off material from the overall process other are simple crystals or membranes of a developing abscess . The scandal is that they did not filter out such crap. Would have cost some extra money.


    Graphene, TiO is a more serious issue as this would be a cheap work around for the lipids (Royalty to Sanofi!) one would need instead.

    Most serious are the various forms of blood damage we know since day 1! where >100 person did die during the first vaxx week.

    I see no added value in following undocumented research based on claimed vaxxines albeit some do good research. Already the fact that 1 out of 10 children did show a heart pathology after getting Pfizer makes this crap a 100000000% no go.

  • Most people are over excited and lack a clear mind due to panic. Most so called nano structures shown in the report are wear off material from the overall process other are simple crystals or membranes of a developing abscess . The scandal is that they did not filter out such crap. Would have cost some extra money.


    Graphene, TiO is a more serious issue as this would be a cheap work around for the lipids (Royalty to Sanofi!) one would need instead.

    Most serious are the various forms of blood damage we know since day 1! where >100 person did die during the first vaxx week.

    I see no added value in following undocumented research based on claimed vaxxines albeit some do good research. Already the fact that 1 out of 10 children did show a heart pathology after getting Pfizer makes this crap a 100000000% no go.

    The people behind this is trying to stablish a case for shutting down the jabbing effort based on poor quality and/or undisclosed ingredients. I understand they are well motivated but the chances of success are very small.

    I certainly Hope to see LENR helping humans to blossom, and I'm here to help it happen.

  • This article was published yesterday, It’s kind of puzzling but as I have no access to the whole paper will leave it here to see if anyone knows more about it.

    Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
    This cohort study investigates the presence of COVID-19 vaccine mRNA in the expressed breast milk of lactating individuals who received the vaccination within…
    jamanetwork.com

    I certainly Hope to see LENR helping humans to blossom, and I'm here to help it happen.

  • This article was published yesterday, It’s kind of puzzling but as I have no access to the whole paper will leave it here to see if anyone knows more about it.

    https://jamanetwork.com/journa…trics/fullarticle/2796427

    This is what trialsite published


    NYU Langone Investigators Find mRNA Vaccine in Milk of Lactating Women

    NYU Langone Investigators Find mRNA Vaccine in Milk of Lactating Women
    A group of pediatric-focused New York-based physicians-scientists affiliated with NYU Langone Hospital—Long Island and the NYU Long Island School of…
    www.trialsitenews.com


    A group of pediatric-focused New York-based physicians-scientists affiliated with NYU Langone Hospital—Long Island and the NYU Long Island School of Medicine conducted a test involving lactating individuals enrolled in the study involving COVID-19 mRNA vaccination with both Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273). Out of 11 samples, the investigators detected mRNA vaccines in 7 samples from 5 different participants at various times up to 45 hours after vaccination. While the authors acknowledge that the U.S. Centers for Disease Control and Prevention (CDC) recommends vaccination with the COVID-19 mRNA vaccines even if breastfeeding, the Long Island-based investigators detected what they refer to as “sporadic presence” with “trace quantities” of COVID-19 vaccine mRNA” in subjects’ expressed breast milk. Although, as the study authors acknowledge, much remains unknown about the mRNA vaccine technology interaction with this vulnerable cohort—it’s declared given the findings that “breastfeeding after COVID-19 mRNA vaccination is safe, particularly beyond 48 hours after vaccination.” TrialSite interjects that ideally, research of this nature is accomplished prior to vaccine/drug approval, particularly when considering the risk associated with vulnerable subjects such as young children and pregnant or lactating persons. That being said, it’s good that studies such as this one are conducted, contributing to the unfolding knowledge about COVID-19 mRNA vaccination.


    Published in JAMA Network, this study represents a first to demonstrate aspects of biodistribution of the COVID-19 mRNA vaccines in mammary cells along with how extracellular vesicles may be involved in the packaging and distribution of the vaccine mRNA to outlying cells.


    TrialSite expresses concern that this kind of research should really be done before a novel life-science-based technology is mass-produced, distributed, and administered particularly in vulnerable societal cohorts such as young children, pregnant, and lactating persons. We suggest it’s good these studies are happening, however, better late than never.


    The Study

    A cohort study, this study involved 11 healthy lactating women who had already been vaccinated with either the mRNA-1273 (n=5) or the BNT162b2 (n=6) COVID-19 mRNA vaccines within 6 months post-delivery.


    The participants collected and immediately placed samples of expressed breast milk (breast milk) in the freezer until the samples were transported to the study laboratory. The samples of breast milk collected prior to vaccination (and up to five days after the jab) were used for controls. The New York-based study team collected 131 total breast milk samples from one to five hours post-vaccination.


    Using sequential centrifugation, the study team isolated extracellular vesicles (EVs) in the breast milk. EVs are “lipid-bound vesicles secreted by cells into the extracellular space” with three subtypes including 1) microvesicles (MVs), 2) exosomes and 3) apoptotic bodies all differentiated based on their biogenesis, release pathways, and other factors such as size, etc. See “Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis.”


    In the lab, the team used a nanoparticle tracking apparatus called ZetaView (Analytik) to identify actual concentrations of EV in the breastmilk. Thereafter, the team represented by corresponding author Dr. Nazeeh Hanna assayed the different milk fractions including whole, expressed, fat, cells and supernatant EVs via a two-step quantitative reverse transcriptase-polymerase chain reaction, determining that vaccine detection limit was 1pg/mL of the expressed breastmilk.


    Study Results

    Published in JAMA Network, the study authors detected 7 samples from 5 different participants at various times up to 45 hours post vaccination. This data is presented in Table 2:


    Detection of Vaccine RNA in Whole Expressed Breast Milk and Extracellular Vesicles in 5 Patients at Various Time Points Postvaccination




    As depicted in the table above, “The mean (SD) yield of EVs isolated from EBM (expressed breast milk) was 9. 110 (5.010) particles/mL”, with a mean (SD) particle size measured at 110.0 (3.0) mn. The study authors found that “the vaccine mRNA appears in higher concentrations in the EVs than in whole milk.”


    Importantly, 48 hours after collection the physician-researchers detected no mRNA vaccine product—not in pre-vaccination or postvaccination EBM samples. The authors also note that they couldn’t detect any mRNA in “EBM fat fraction or the EBM cell pellets.”


    What are the implications?

    First, the authors seek to minimize any negative implications or connotations associated with these findings by noting that there was only a “sporadic presence” of detected mRNA vaccine in EBM at “trace quantities,” suggesting that use of the vaccine for breastfeeding women after COVID-19 mRNA vaccination is “safe,” particularly, “48 hours after vaccination.”


    Highlighting the novel aspects of this study, the team wrote that the data “demonstrate for the first time to our knowledge the biodistribution of COVID-19 vaccine mRNA to mammary cells and the potential ability of tissue EVs to package the vaccine mRNA that can be transported to distant cells.”


    This media would remind all that typically this kind of study—and finding, should occur before a drug or vaccine is authorized and promoted for mass use, especially when it comes to young children and pregnant persons. Of course, with COVID-19 and the emergency status standard, protocols were bypassed.


    Evidencing to some extent that COVID-19 has converted whole cohorts of society into research subjects, the authors pondered aloud that “Little has been reported on lipid nanoparticle biodistribution and localization in human tissues after COVID-19 mRNA vaccination.” Again, normally such work would be done well before approval of vaccines. The authors cited a rat study three days after vaccination with an mRNA vaccine finding that “low vaccine mRNA levels were detected in the heart, lung, testis, and brain tissues.”


    Again, without truly understanding how the mRNA vaccines work in their entirety, the authors “speculate that following the vaccine administration, lipid nanoparticles containing the vaccine mRNA are carried to mammary glands via hematogenous and/or lymphatic routes.” TrialSite was the first media to public animal biodistribution data associated with BNT162b2 via a freedom of information act request in Canada and Japan.


    Further speculating, the authors suggest perhaps when vaccinated, the mRNA is released “into mammary cell cytosol” which could be “recruited into developing EVs that are later secreted in EBM.”


    Study Limitations

    First, the study sample size was small, and the authors acknowledge a lack of any functional ability to understand if the detected mRNA vaccine was translationally active. What about any cumulative vaccine mRNA exposure after frequent breastfeeding in infants? This wasn’t tested.


    Interestingly, the authors felt the need to insert in the study limitations the comment that they “believe it is safe to breastfeed after maternal COVID-19 vaccination,” yet qualify “caution is warranted about breastfeeding children younger than 6 months in the first 48 hours after maternal vaccination until more safety studies are conducted.”


    Moreover, different vaccinations can interact and impact immune response, as TrialSite recently chronicled when discussing the concomitant administration of both the COVID-19 and influenza vaccines. They note the potential for “interference of COVID-19 vaccine mRNA with the immune response to multiple routine vaccines given to infants during the first 6 months of age.” Of course, there is no data for the medical establishment to understand the impacts at this point other than studies involving other vaccines at this tender young age.


    They urge that “lactating individuals be included in future vaccination trials to better evaluate the effect of mRNA vaccines on lactating outcomes.” TrialSite reminds that this kind of activity usually happens before mass use of a vaccine or drug.


    Funding

    NYU Langone Hospital-Long Island, Department of Pediatrics and NYU Long Island School of Medicine funded the study


    Lead Research/Investigator



    Nazeeh Hanna, MD, Division of Neonatology, Department of Pediatrics, NYU Langone Hospital–Long Island, NYU Long Island School of Medicine; Corresponding Author

    Ari Heffes-Doon, MD, Division of Neonatology, Department of Pediatrics, NYU Langone Hospital–Long Island, NYU Long Island School of Medicine

    Xinhua Lin, PhD, Women and Children’s Research Laboratory, NYU Long Island School of Medicine, Mineola, New York

    Claudia Manzano De Mejia, MD, Women and Children’s Research Laboratory, NYU Long Island School of Medicine, Mineola, New York

    Bishoy Botros, BS, Women and Children’s Research Laboratory, NYU Long Island School of Medicine, Mineola, New York

    Ellen Gurzenda, BA, Women and Children’s Research Laboratory, NYU Long Island School of Medicine, Mineola, New York

    Amrita Nayak, MD, Division of Neonatology, Department of Pediatrics, NYU Langone Hospital–Long Island, NYU Long Island School of Medicine

  • The recent White House guidance for people to take the bivalent BA.5 Covid-19 booster vaccine concurrently with the influenza shot was clearly not based on evidence. It's immunology 101 that introducing multiple antigens simultaneously will generally reduce the immune response to each antigen. However, that didn't stop the current heads of the executive branch of government from issuing their flippant comment that God gave us two arms so we could be vaccinated in each one simultaneously. A truly insensitive, frankly bizarre, and definitely inappropriate comment made by Biden’s Coronavirus Response Coordinator Dr. Ashish Jha.


    Are we Following Science?

    This media has expressed concern about questionable commitment to science associated with this current administration (to be fair, we were just as critical with the last one). A confluence socio-economic, political, and even cultural interests at the top of American society could be influencing ongoing pandemic-related decision-making, unfortunately possibly even more than what should be driving such decision-making: the data from new studies often reported by this platform.

    Just a comment here. Personally - I'd want two trips to get two different vaccines, for this reason.


    As for public health overall it is probably true, regrettably, that you will get better overall coverage and fewer deaths with combined vaccination.


    Why?


    (1) The difference in response is not very significant in the context of protection from covid

    (2) As a matter of behavioural science, many people, rather than go get two vaccine shots at separate times, will get only one.


    As for whether this simplification is a good idea I don't know - I'd just point out that health authorities in the UK are also advising getting both vaccinations at the same time.


    They have a laser-like focus on reducing overall hospital occupancy this winter. No other agenda, you can be sure.


    Perhaps they are all wrong?


    More significant than the unproven but likely diminution in response from multiple jabs is the fact that the Flu season starts later in the year and Flu protection reduces with every month after the jab. So September is too early to be getting a Flu jab.

  • flu shots are recommended from September 1st thru mid October in the states. The fact of the matter is the Whitehouse has recommended getting flu and Covid jabs at the same time without alerting the public to the possibility of the Covid jab being less effective. It's promoting death for some!!!

  • So called anti Vaxer have been right all along!!!!!!!!


    Routine childhood vaccines may raise the risk of asthma by a THIRD, shock Government-funded study finds — but experts say benefits still outweigh risk

    Child vaccines may raise the risk of asthma by a THIRD
    The CDC-funded study, led by Colorado University, found children who had all or most of their childhood shots had a 36 per cent higher risk of being diagnosed…
    www.dailymail.co.uk


    It has been a question pondered by scientists mostly on the fringes for decades.


    Now a federally-funded study has found a possible link between vaccines containing aluminum and a higher risk of asthma in children.


    Results showed children who received all or most of their routine childhood shots had a 36 per cent higher risk of being diagnosed with persistent asthma by age five than kids who got fewer vaccines.


    Experts and health officials say the research has important shortcomings and is not a reason to change current vaccine programs that are proven to save lives.


    The study doesn't claim aluminum causes the breathing condition and instead suggests a casual association. More work is needed to confirm the connection and find out why it has not been detected before.


    Aluminum has been used as in tiny doses an additive in lifesaving vaccines since the 1930s — for infections like tetanus, hepatitis and flu — with little evidence to suggest it is not safe.


    The role of vitamin D in toxic metal absorption: a review

    https://www.tandfonline.com/do…0vitamin%20D%20metabolism.


    Abstract

    Vitamin D increases intestinal calcium and phosphate absorption. Not so well known, however, is that vitamin D stimulates the co-absorption of other essential minerals like magnesium, iron, and zinc; toxic metals including lead, cadmium, aluminum, and cobalt; and radioactive isotopes such as strontium and cesium. Vitamin D may contribute to the pathologies induced by toxic metals by increasing their absorption and retention. Reciprocally, lead, cadmium, aluminum, and strontium interfere with normal vitamin D metabolism by blocking renal synthesis of 1,25-dihydroxyvitamin D. This is the first review of the role of the vitamin D endocrine system in metal toxicology.

  • Covid-19 vaccine administration must stop’ – Dr Aseem Malhotra’s MUST READ paper on mRNA vaccines

    ‘Covid-19 vaccine administration must stop’ – Dr Aseem Malhotra’s MUST READ paper on mRNA vaccines
    Dr Malhotra's look at data relating to mRNA vaccines reveals holes in the Pfizer mRNA trials and findings drawn from pharmacovigilance data.
    www.biznews.com


    After the untimely cardiac death of his father, Dr Aseem Malhotra, a consultant cardiologist and an internationally renowned expert in the prevention, diagnosis and management of heart disease, who was one of the first to receive the double Pfizer Covid-19 mRNA vaccine in January 2021, started to thoroughly examine the real world data relating to mRNA vaccines. His examination culminated in a two-part paper titled ‘Curing the pandemic of misinformation on Covid-19 mRNA vaccines through real evidence-based medicine’, the public release of which was embargoed until late last night. The paper reveals glaring holes in the pivotal Pfizer mRNA trials and findings drawn from available pharmacovigilance data (as well as the absence of robust safety data), which led Dr Malhotra to describe the mRNA vaccine roll-out into the entire population as “a reckless gamble, at best”. Endorsed by many leading medical professionals, the paper emphasises that conversations in which the difference between the absolute and relative risk reduction afforded by the Covid-19 mRNA vaccines was explained to patients (a mere 0.84%, as suggested by the Pfizer mRNA trial) simply did not happen, not to mention the “known, unknown and as yet to be fully quantified harms”. Published in the Journal of Insulin Resistance, the paper has led to calls for the suspension of all Covid-19 vaccines. – Nadya Swart

  • HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection

    HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection
    Background Evidence has shown that a large proportion of SARS-CoV-2 infected individuals do not experience symptomatic disease. Owing to its critical role in…
    www.medrxiv.org


    Abstract

    Background Evidence has shown that a large proportion of SARS-CoV-2 infected individuals do not experience symptomatic disease. Owing to its critical role in immune response, we hypothesized that variation in the human leukocyte antigen (HLA) loci may underly asymptomatic infection.


    Methods We enrolled 29,947 individuals registered in the National Marrow Donor Program for whom high-resolution HLA genotyping data were available in a smartphone-based study designed to track COVID-19 symptoms and outcomes. Among 21,893 individuals who completed the baseline survey, our discovery (N=640) and replication (N=788) cohorts were comprised of self-identified White subjects who reported a positive test result for SARS-CoV-2. We tested for association of five HLA loci (HLA-A, -B, -C, -DRB1, -DQB1) with asymptomatic vs. symptomatic infection.


    Results HLA-B*15:01 was significantly increased in asymptomatic individuals in the discovery cohort compared to symptomatic (OR = 2.45; 95%CI 1.38-4.24, p = 0.0016, pcorr = 0.048), and we reproduced this association in the replication cohort (OR= 2.32; 95%CI = 1.10-4.43, p = 0.017). We found robust association of HLA-B*15:01 in the combined dataset (OR=2.40 95% CI = 1.54-3.64; p = 5.67 x10−5) and observed that homozygosity of this allele increases more than eight times the chance of remaining asymptomatic after SARS-CoV-2 infection (OR = 8.58, 95%CI = 1.74-34.43, p = 0.003). Finally, we demonstrated the association of HLA-B*15:01 with asymptomatic SARS-Cov-2 infection is enhanced by the presence of HLA-DRB1*04:01


    Conclusion HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance.


    And let me add HLA-B 1501 expression is regulated by Vitamin D!

  • Aluminum has been used as in tiny doses an additive in lifesaving vaccines since the 1930s

    Using Aluminium is just a business decision. $$$$$$ for your risk. With ALU you can reduce the amount of serum by at least 3x! About 8% of all people have a genetic incompatibility with Aluminium, what can lead also to breast cancer in woman just for using the wrong deo!!

  • Endorsed by many leading medical professionals, the paper emphasises that conversations in which the difference between the absolute and relative risk reduction afforded by the Covid-19 mRNA vaccines was explained to patients (a mere 0.84%, as suggested by the Pfizer mRNA trial) simply did not happen, not to mention the “known, unknown and as yet to be fully quantified harms”.

    We now see it in the Swiss hospital statistics. Vaxx:unvax ratio between 5::1 and 10::1. Average 7::1.

    https://www.covid19.admin.ch/de/vaccination/status
    Once more:: "unkown means unknown vaxx status = 2,3,4 x vaxx".


    RNA gen therapy is damaging and more deadly than Omicron.